{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:10:47Z","timestamp":1793286647040,"version":"4.5.0"},"reference-count":118,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:p>Chronic gastritis (CG), particularly when associated with <jats:italic toggle=\"yes\">Helicobacter pylori<\/jats:italic> (<jats:italic toggle=\"yes\">H. pylori<\/jats:italic>) infection, is a significant precursor to gastric cancer (GC), a leading cause of cancer-related deaths worldwide. The persistent inflammation in CG, driven by factors such as <jats:italic toggle=\"yes\">H. pylori<\/jats:italic>, induces oxidative stress and DNA damage in gastric epithelial cells, which can lead to malignant transformation. Atrophic gastritis, a form of CG, can be categorized into autoimmune and <jats:italic toggle=\"yes\">H. pylori<\/jats:italic>-associated types, both of which increase the risk of GC development, particularly when compounded by external factors like smoking and dietary habits. This manuscript explores the pathophysiological mechanisms underlying CG and its progression to GC, highlighting the critical role of metabolomics in advancing our understanding of these processes. Metabolomics, the comprehensive study of metabolites, offers a novel approach to identifying biomarkers that could facilitate early detection and improve the accuracy of GC diagnosis and prognosis. The analysis of metabolic alterations, particularly in glucose, lipid, and amino acid metabolism, reveals distinct biochemical pathways associated with the progression from benign gastritis to malignancy. Integrating metabolomic profiling with traditional diagnostic methods can revolutionize GC management, enabling more personalized treatment strategies and improving clinical outcomes. However, significant challenges remain, including the need to validate biomarkers across diverse populations and standardize metabolomic techniques. Future research should address these challenges to fully realize the potential of metabolomics in early GC detection and treatment, ultimately aiming to reduce the global burden of this deadly disease.<\/jats:p>","DOI":"10.1097\/ms9.0000000000002977","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T15:00:18Z","timestamp":1738249218000},"page":"583-597","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Serum metabolic profiling analysis of chronic gastritis and gastric cancer by untargeted metabolomics"],"prefix":"10.1097","volume":"87","author":[{"given":"Hadiya","family":"Afzal","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Shaukat","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Zain","family":"Ul Haq","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawal","family":"Khaliq","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Zahid","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laiba","family":"Shakeel","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Abdul","family":"Wasay Zuberi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aymar","family":"Akilimali","sequence":"additional","affiliation":[{"name":"Department of Research, Medical Research Circle (MedReC), Goma, Democratic Republic of the Congo"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"key":"R2-20250623","doi-asserted-by":"crossref","first-page":"e12984","DOI":"10.1111\/hel.12984","article-title":"Metabolic alterations in patients with Helicobacter pylori-related gastritis: the H. pylori-gut microbiota-metabolism axis in progression of the chronic inflammation in the gastric mucosa","volume":"28","author":"Zang","year":"2023","journal-title":"Helicobacter"},{"key":"R3-20250623","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1615\/JEnvironPatholToxicolOncol.2018026839","article-title":"Chronic atrophic gastritis: a review","volume":"37","author":"Li","year":"2018","journal-title":"J Environ Pathol Toxicol Oncol"},{"key":"R4-20250623","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1080\/00325481.2022.2063604","article-title":"The \u2018reversibility\u2019 of chronic atrophic gastritis after the eradication of Helicobacter pylori","volume":"134","author":"Yang","year":"2022","journal-title":"Postgrad Med"},{"key":"R5-20250623","doi-asserted-by":"crossref","first-page":"636917","DOI":"10.3389\/fonc.2021.636917","article-title":"Serum metabolic profiling analysis of chronic gastritis and gastric cancer by untargeted metabolomics","volume":"11","author":"Yu","year":"2021","journal-title":"Front Oncol"},{"key":"R6-20250623","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.4251\/wjgo.v16.i6.2419","article-title":"Analysis of metabolic characteristics of metabolic syndrome in elderly patients with gastric cancer by non-targeted metabolomics","volume":"16","author":"Zhang","year":"2024","journal-title":"World J Gastrointest Oncol"},{"key":"R7-20250623","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2478\/raon-2024-0028","article-title":"Pathogenesis and potential reversibility of intestinal metaplasia \u2212 a milestone in gastric carcinogenesis","volume":"58","author":"Drnovsek","year":"2024","journal-title":"Radiol Oncol"},{"key":"R8-20250623","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.3390\/cancers16122254","article-title":"Non-invasive markers for the detection of gastric precancerous conditions","volume":"16","author":"Roma\u0144czyk","year":"2024","journal-title":"Cancers (Basel)"},{"key":"R9-20250623","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.3748\/wjg.v29.i23.3733","article-title":"Paradoxical association between dyspepsia and autoimmune chronic atrophic gastritis: insights into mechanisms, pathophysiology, and treatment options","volume":"29","author":"Rossi","year":"2023","journal-title":"World J Gastroenterol"},{"key":"R10-20250623","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3390\/diagnostics11010134","article-title":"Endoscopic ultrasound vs. computed tomography for gastric cancer staging: a network meta-analysis","volume":"11","author":"Ungureanu","year":"2021","journal-title":"Diagnostics"},{"key":"R11-20250623","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(95)91084-0","article-title":"Long-term sequelae of Helicobacter pylori gastritis","volume":"345","author":"Kuipers","year":"1995","journal-title":"Lancet"},{"key":"R12-20250623","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.3748\/wjg.v23.i32.5945","article-title":"Changes with aging in gastric biomarkers levels and in biochemical factors associated with Helicobacter pylori infection in asymptomatic Chinese population","volume":"23","author":"Shan","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"32","key":"R13-20250623","article-title":"Pepsinogen II can be a potential surrogate marker of morphological changes in corpus before and after H. pylori eradication","volume":"2014","author":"Massarrat","year":"2014","journal-title":"Wiley Online Library S Massarrat, A Haj-Sheykholeslami, A Mohamadkhani, N Zendehdel, A AliasgariBioMed Research International, 2014\u2022Wiley Online Library"},{"key":"R14-20250623","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-018-0469-6","article-title":"H. pylori infection and extra-gastroduodenal diseases","volume":"25","author":"Tsay","year":"2018","journal-title":"J Biomed Sci"},{"key":"R15-20250623","article-title":"Review: extragastric diseases and Helicobacter pylori","volume":"25 Suppl 1:1","author":"Pellicano","year":"2020","journal-title":"Helicobacter"},{"key":"R16-20250623","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.3748\/wjg.v24.i28.3071","article-title":"Helicobacter pylori in human health and disease: mechanisms for local gastric and systemic effects","volume":"24","author":"Bravo","year":"2018","journal-title":"World J Gastroenterol"},{"key":"R17-20250623","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.3748\/wjg.v20.i18.5226","article-title":"Metabolic consequences of Helicobacter pylori infection and eradication","volume":"20","author":"Buz\u00e1s","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R18-20250623","doi-asserted-by":"crossref","first-page":"e000182","DOI":"10.1136\/bmjgast-2017-000182","article-title":"Changes in the gut microbiota composition and the plasma ghrelin level in patients with Helicobacter pylori- infected patients with eradication therapy","volume":"4","author":"Yanagi","year":"2017","journal-title":"BMJ Open Gastroenterol"},{"key":"R19-20250623","doi-asserted-by":"crossref","first-page":"12809","DOI":"10.3748\/wjg.v20.i36.12809","article-title":"Role of Helicobacter pylori infection on nutrition and metabolism","volume":"20","author":"Franceschi","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R20-20250623","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/MEG.0000000000001014","article-title":"Helicobacter pylori infection is positively associated with an increased BMI, irrespective of socioeconomic status and other confounders: a cohort study","volume":"30","author":"Suki","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R21-20250623","doi-asserted-by":"crossref","first-page":"14467","DOI":"10.1038\/s41598-017-14106-4","article-title":"Helicobacter pylori colonization and obesity - a Mendelian randomization study","volume":"7","author":"Den Hollander","year":"2017","journal-title":"Sci Rep"},{"key":"R22-20250623","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1365-2036.2011.04610.x","article-title":"Randomised clinical trial: Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study","volume":"33","author":"Lane","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"R23-20250623","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.3748\/wjg.15.2701","article-title":"Helicobacter pylori infection and endocrine disorders: is there a link?","volume":"15","author":"Papamichael","year":"2009","journal-title":"World J Gastroenterol"},{"key":"R24-20250623","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.3748\/wjg.v18.i21.2674","article-title":"Eradication of Helicobacter pylori increases childhood growth and serum acylated ghrelin levels","volume":"18","author":"Yang","year":"2012","journal-title":"World J Gastroenterol"},{"key":"R25-20250623","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ejim.2009.07.013","article-title":"The prevalence of Helicobacter pylori in obese subjects","volume":"20","author":"Arslan","year":"2009","journal-title":"Eur J Intern Med"},{"key":"R26-20250623","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1172\/JCI88883","article-title":"The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis","volume":"127","author":"Crewe","year":"2017","journal-title":"J Clin Invest"},{"key":"R27-20250623","first-page":"7","article-title":"H. pylori eradication treatment causes alterations in the gut microbiota and blood lipid levels","volume":"7","author":"Mart\u00edn-N\u00fa\u00f1ez","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"R28-20250623","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-019-3787-8","article-title":"Helicobacter pylori infection as a risk factor for serum bilirubin change and less favourable lipid profiles: a hospital-based health examination survey","volume":"19","author":"Zhao","year":"2019","journal-title":"BMC Infect Dis"},{"key":"R29-20250623","doi-asserted-by":"crossref","first-page":"e0234433","DOI":"10.1371\/journal.pone.0234433","article-title":"The association of Helicobacter pylori infection with serum lipid profiles: an evaluation based on a combination of meta-analysis and a propensity score-based observational approach","volume":"15","author":"Shimamoto","year":"2020","journal-title":"PLoS One"},{"key":"R30-20250623","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fphar.2018.00009","article-title":"The Turkish medicines and medical devices agency: comparison of its registration process with Australia, Canada, Saudi Arabia, and Singapore.","volume":"9","author":"Mashaki Ceyhan","year":"2018","journal-title":"Front Pharmacol"},{"key":"R31-20250623","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.dsx.2020.05.009","article-title":"A systematic review and meta-analysis of the prevalence of Helicobacter pylori in patients with diabetes","volume":"14","author":"Mansori","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"R32-20250623","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.diabres.2012.11.012","article-title":"Association between Helicobacter pylori infection and diabetes mellitus: a meta-analysis of observational studies","volume":"99","author":"Zhou","year":"2013","journal-title":"Diabetes Res Clin Pract"},{"key":"R34-20250623","doi-asserted-by":"crossref","first-page":"1479164120953626","DOI":"10.1177\/1479164120953626","article-title":"Relation of Helicobacter pylori infection to peripheral arterial stiffness and 10-year cardiovascular risk in subjects with diabetes mellitus","volume":"17","author":"Yang","year":"2020","journal-title":"Diab Vasc Dis Res"},{"key":"R35-20250623","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/abr.abr_248_19","article-title":"Prevalence of helicobacter pylori infection among type 2 diabetes mellitus","volume":"9","author":"Bener","year":"2020","journal-title":"Adv Biomed Res"},{"key":"R36-20250623","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fimmu.2020.00011","article-title":"calreticulin blockade attenuates murine acute lung injury by inducing polarization of M2 subtype macrophages.","volume":"11","author":"Jiang","year":"2020","journal-title":"Front Immunol"},{"key":"R37-20250623","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fimmu.2020.01390","article-title":"Alterations in circulating fatty acid are associated with gut microbiota dysbiosis and inflammation in multiple sclerosis","volume":"11","author":"Saresella","year":"2020","journal-title":"Front Immunol"},{"key":"R38-20250623","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature12726","article-title":"Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation","volume":"504","author":"Arpaia","year":"2013","journal-title":"Nature"},{"key":"R39-20250623","first-page":"1","article-title":"Prostaglandin E2 and cancer: insight into tumor progression and immunity","volume":"9","author":"Finetti","year":"2020","journal-title":"Biology (Basel)"},{"key":"R40-20250623","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.ajpath.2018.01.011","article-title":"Microbiota-derived indole metabolites promote human and murine intestinal homeostasis through regulation of interleukin-10 receptor","volume":"188","author":"Alexeev","year":"2018","journal-title":"Am J Pathol"},{"key":"R41-20250623","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1073\/pnas.0906112107","article-title":"The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation","volume":"107","author":"Bansal","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R42-20250623","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00000478-199610000-00001","article-title":"Classification and grading of gastritis. The updated Sydney system. international workshop on the histopathology of Gastritis, Houston 1994","volume":"20","author":"Dixon","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"R43-20250623","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/003655202320621418","article-title":"The serological gastric biopsy: a non-endoscopical diagnostic approach in management of the dyspeptic patient: significance for primary care based on a survey of the literature","volume":"37","author":"Korstanje","year":"2002","journal-title":"Scand J Gastroenterol Suppl"},{"key":"R44-20250623","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1080\/003655200750023138","article-title":"Evaluation of blood tests to predict normal gastric mucosa","volume":"35","author":"Oksanen","year":"2000","journal-title":"Scand J Gastroenterol"},{"key":"R45-20250623","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s004410051104","article-title":"Immunocytochemistry and in situ hybridization studies of pepsinogen C-producing cells in developing rat fundic glands","volume":"293","author":"Ge","year":"1998","journal-title":"Cell Tissue Res"},{"key":"R48-20250623","doi-asserted-by":"crossref","first-page":"e12872","DOI":"10.1111\/hel.12872","article-title":"Pepsinogen II in gastritis and Helicobacter pylori infection","volume":"27","author":"Di Mario","year":"2022","journal-title":"Helicobacter"},{"key":"R49-20250623","doi-asserted-by":"crossref","first-page":"e0274938","DOI":"10.1371\/journal.pone.0274938","article-title":"Diagnostic performances of pepsinogens and gastrin-17 for atrophic gastritis and gastric cancer in Mongolian subjects","volume":"17","author":"Dondov","year":"2022","journal-title":"PLoS One"},{"key":"R50-20250623","doi-asserted-by":"crossref","first-page":"e0218274","DOI":"10.1371\/journal.pone.0218274","article-title":"Exploring the impact of Helicobacter pylori on gut microbiome composition","volume":"14","author":"Dash","year":"2019","journal-title":"PLoS One"},{"key":"R51-20250623","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.3748\/wjg.v27.i33.5575","article-title":"Characterization of gut microbiome and metabolome in Helicobacter pylori patients in an underprivileged community in the United States","volume":"27","author":"White","year":"2021","journal-title":"World J Gastroenterol"},{"key":"R52-20250623","doi-asserted-by":"crossref","first-page":"192","DOI":"10.25100\/cm.v44i3.1263","article-title":"Gastric cancer: overview","volume":"44","author":"Piazuelo","year":"2013","journal-title":"Colomb Med (Cali)"},{"key":"R53-20250623","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41571-023-00747-0","article-title":"Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention","volume":"20","author":"Thrift","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"R54-20250623","first-page":"S6","article-title":"Helicobacter Pylori and Gastric Cancer: A State of the Art Review","volume":"8","author":"Ishaq","year":"2015","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"R55-20250623","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/milmed\/165.1.21","article-title":"Association of helicobacter pylori infection with gastric cancer","volume":"165","author":"Alexander","year":"2000","journal-title":"Mil Med"},{"key":"R56-20250623","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R57-20250623","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4103\/1477-3163.146506","article-title":"Gastric cancer review","volume":"13","author":"Carcas","year":"2014","journal-title":"J Carcinog"},{"key":"R58-20250623","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3892\/ijo.2017.4000","article-title":"Gastric cancer: metabolic and metabolomics perspectives (Review)","volume":"51","author":"Xiao","year":"2017","journal-title":"Int J Oncol"},{"key":"R59-20250623","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.2147\/OTT.S189687","article-title":"Metabolic reprogramming results in abnormal glycolysis in gastric cancer: a review","volume":"12","author":"Liu","year":"2019","journal-title":"Onco Targets Ther"},{"key":"R60-20250623","doi-asserted-by":"crossref","first-page":"60053","DOI":"10.18632\/oncotarget.11049","article-title":"Metabolomic analysis reveals altered metabolic pathways in a rat model of gastric carcinogenesis","volume":"7","author":"Gu","year":"2016","journal-title":"Oncotarget"},{"key":"R61-20250623","doi-asserted-by":"crossref","first-page":"1224832","DOI":"10.3389\/fendo.2023.1224832","article-title":"GADD45B regulates the carcinogenesis process of chronic atrophic gastritis and the metabolic pathways of gastric cancer","volume":"14","author":"Xu","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R62-20250623","first-page":"797","article-title":"Citrate induces apoptotic cell death: a promising way to treat gastric carcinoma?","volume":"31","author":"Lu","year":"2011","journal-title":"Anticancer Res"},{"key":"R63-20250623","doi-asserted-by":"crossref","first-page":"14632","DOI":"10.1038\/s41598-022-19061-3","article-title":"Metabolite biomarker discovery for human gastric cancer using dried blood spot mass spectrometry metabolomic approach","volume":"12","author":"Wu","year":"2022","journal-title":"Sci Rep"},{"key":"R64-20250623","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1615\/CritRevEukaryotGeneExpr.2015014360","article-title":"Advances in molecular biomarkers for gastric cancer","volume":"25","author":"Zheng","year":"2015","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"R65-20250623","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cca.2014.02.001","article-title":"Serum proteomics for gastric cancer","volume":"431","author":"Liu","year":"2014","journal-title":"Clinica Chimica Acta"},{"key":"R66-20250623","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.3390\/cancers12102904","article-title":"Screening for early gastric cancer using a noninvasive urine metabolomics approach","volume":"12","author":"Kwon","year":"2020","journal-title":"Cancers (Basel)"},{"key":"R67-20250623","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1634\/theoncologist.2014-0378","article-title":"Prospective comprehensive genomic profiling of advanced gastric carcinoma cases reveals frequent clinically relevant genomic alterations and new routes for targeted therapies","volume":"20","author":"Ali","year":"2015","journal-title":"Oncologist"},{"key":"R68-20250623","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/bjc.2011.592","article-title":"Serum biomarker panels for the diagnosis of gastric adenocarcinoma","volume":"106","author":"Ahn","year":"2012","journal-title":"Br J Cancer"},{"key":"R69-20250623","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1021\/acs.jproteome.6b00281","article-title":"Metabolomic analysis of gastric cancer progression within the Correa\u2019s cascade using ultraperformance liquid chromatography-mass spectrometry","volume":"15","author":"Kuligowski","year":"2016","journal-title":"J Proteome Res"},{"key":"R70-20250623","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jpba.2019.06.025","article-title":"Non-targeted metabolomics reveals diagnostic biomarker in the tongue coating of patients with chronic gastritis","volume":"174","author":"Mu","year":"2019","journal-title":"J Pharm Biomed Anal"},{"key":"R71-20250623","doi-asserted-by":"crossref","first-page":"e14115","DOI":"10.7717\/peerj.14115","article-title":"Targeted metabolomic profiles of serum amino acids and acylcarnitines related to gastric cancer","volume":"10","author":"Li","year":"2022","journal-title":"PeerJ"},{"key":"R72-20250623","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.21037\/tcr-21-794","article-title":"Abnormal arginine metabolism is associated with prognosis in patients of gastric cancer","volume":"10","author":"Shi","year":"2021","journal-title":"Transl Cancer Res"},{"key":"R73-20250623","doi-asserted-by":"crossref","first-page":"750","DOI":"10.3390\/ijms19030750","article-title":"Use of metabolomics as a complementary omic approach to implement risk criteria for first-degree relatives of gastric cancer patients","volume":"19","author":"Corona","year":"2018","journal-title":"Int J Mol Sci"},{"key":"R74-20250623","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-17921-x","article-title":"Plasma sample based analysis of gastric cancer progression using targeted metabolomics","volume":"7","author":"Lario","year":"2017","journal-title":"Sci Rep"},{"key":"R75-20250623","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1021\/acs.jproteome.2c00295","article-title":"Metabolomics reveals novel serum metabolic signatures in gastric cancer by a mass spectrometry platform","volume":"22","author":"Yu","year":"2023","journal-title":"J Proteome Res"},{"key":"R76-20250623","doi-asserted-by":"crossref","first-page":"110000","DOI":"10.18632\/oncotarget.21314","article-title":"Serum metabolomic profiling of human gastric cancer and its relationship with the prognosis","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"R77-20250623","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/postgradmedj-2020-139183","article-title":"Serum pepsinogen levels and OLGA\/OLGIM staging in the assessment of atrophic gastritis types","volume":"98","author":"Koc","year":"2022","journal-title":"Postgrad Med J"},{"key":"R78-20250623","doi-asserted-by":"crossref","first-page":"0300060520914826","DOI":"10.1177\/0300060520914826","article-title":"Diagnostic value of serum pepsinogen I, pepsinogen II, and gastrin-17 levels for population-based screening for early-stage gastric cancer","volume":"48","author":"Wang","year":"2020","journal-title":"J Int Med Res"},{"issue":"16","key":"R79-20250623","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.88563","article-title":"Metabolomics: basic Principles and Strategies","volume":"10","author":"Nalbantoglu","year":"2019","journal-title":"Mol Med"},{"key":"R80-20250623","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrm3314","article-title":"Metabolomics: the apogee of the omics trilogy","volume":"13","author":"Patti","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R81-20250623","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3390\/metabo11080558","article-title":"Unravelling plant responses to stress-the importance of targeted and untargeted metabolomics","volume":"11","author":"Allwood","year":"2021","journal-title":"Metabolites"},{"key":"R82-20250623","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.tplants.2018.09.011","article-title":"Contribution of untargeted metabolomics for future assessment of biotech crops","volume":"23","author":"Christ","year":"2018","journal-title":"Trends Plant Sci"},{"key":"R83-20250623","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.tibs.2017.01.004","article-title":"Metabolomics: a Primer","volume":"42","author":"Liu","year":"2017","journal-title":"Trends Biochem Sci"},{"key":"R84-20250623","doi-asserted-by":"crossref","first-page":"30.2.1\u201330.2.24","DOI":"10.1002\/0471142727.mb3002s98","article-title":"Targeted Metabolomics","volume":"98","author":"Roberts","year":"2012","journal-title":"Curr Protoc Mol Biol"},{"key":"R85-20250623","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2217\/pgs.15.20","article-title":"Pharmacometabonomics in humans: a new tool for personalized medicine","volume":"16","author":"Everett","year":"2015","journal-title":"Pharmacogenomics"},{"key":"R86-20250623","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ccc.2019.08.008","article-title":"Metabolomics and the microbiome as biomarkers in sepsis","volume":"36","author":"Lee","year":"2020","journal-title":"Crit Care Clin"},{"key":"R87-20250623","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1097\/CCM.0000000000001249","article-title":"rapid diagnosis of infection in the critically Ill, a multicenter study of molecular detection in bloodstream infections, pneumonia, and sterile site infections","volume":"43","author":"Vincent","year":"2015","journal-title":"Crit Care Med"},{"key":"R88-20250623","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1039\/C6MB00656F","article-title":"Mass spectrometry for the discovery of biomarkers of sepsis","volume":"13","author":"Ludwig","year":"2017","journal-title":"Mol Biosyst"},{"key":"R89-20250623","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nature04648","article-title":"Pharmaco-metabonomic phenotyping and personalized drug treatment","volume":"440","author":"Clayton","year":"2006","journal-title":"Nature"},{"key":"R90-20250623","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3390\/molecules22071173","article-title":"Novel applications of metabolomics in personalized medicine: a mini-review","volume":"22","author":"Li","year":"2017","journal-title":"Molecules"},{"key":"R91-20250623","doi-asserted-by":"crossref","first-page":"130318","DOI":"10.3389\/fbioe.2015.00023","article-title":"Analytical methods in untargeted metabolomics: state of the art in 2015","volume":"3","author":"Alonso","year":"2015","journal-title":"Front Bioeng Biotechnol"},{"key":"R92-20250623","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/j.1742-4658.2007.05675.x","article-title":"Recent applications of NMR spectroscopy in plant metabolomics","volume":"274","author":"Ward","year":"2007","journal-title":"FEBS J"},{"key":"R93-20250623","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/cem.859","article-title":"Correlation optimized warping and dynamic time warping as preprocessing methods for chromatographic data","volume":"18","author":"Tomasi","year":"2004","journal-title":"J Chemom"},{"key":"R94-20250623","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1021\/ac300698c","article-title":"XCMS online: a web-based platform to process untargeted metabolomic data","volume":"84","author":"Tautenhahn","year":"2012","journal-title":"Anal Chem"},{"key":"R95-20250623","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11306-006-0037-z","article-title":"Statistical strategies for avoiding false discoveries in metabolomics and related experiments","volume":"2","author":"Broadhurst","year":"2006","journal-title":"Metabolomics"},{"key":"R96-20250623","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3390\/metabo2040775","article-title":"A guideline to univariate statistical analysis for LC\/MS-based untargeted metabolomics-derived data","volume":"2","author":"Vinaixa","year":"2012","journal-title":"Metabolites"},{"key":"R97-20250623","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3390\/metabo12010087","article-title":"A checklist for reproducible computational analysis in clinical metabolomics research","volume":"12","author":"Du","year":"2022","journal-title":"Metabolites"},{"key":"R98-20250623","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4292\/wjgpt.v4.i4.97","article-title":"Metabolomics as a diagnostic tool in gastroenterology","volume":"4","author":"De Preter","year":"2013","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"R99-20250623","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1373\/clinchem.2007.089011","article-title":"Metabolomics identifies perturbations in human disorders of propionate metabolism","volume":"53","author":"Wikoff","year":"2007","journal-title":"Clin Chem"},{"key":"R100-20250623","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1002\/rcm.3708","article-title":"A serum metabolomic investigation on hepatocellular carcinoma patients by chemical derivatization followed by gas chromatography\/mass spectrometry","volume":"22","author":"Xue","year":"2008","journal-title":"Rapid Commun Mass Spectrom"},{"key":"R101-20250623","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrd728","article-title":"Metabonomics: a platform for studying drug toxicity and gene function","volume":"1","author":"Nicholson","year":"2002","journal-title":"Nat Rev Drug Discovery"},{"key":"R102-20250623","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1590\/S0100-879X2011007500158","article-title":"Serum metabolic profiling of human gastric cancer based on gas chromatography\/mass spectrometry","volume":"45","author":"Song","year":"2012","journal-title":"Braz J Med Biol Res"},{"key":"R103-20250623","doi-asserted-by":"crossref","first-page":"e32094","DOI":"10.1371\/journal.pone.0032094","article-title":"A pivotal role of vitamin B9 in the maintenance of regulatory T cells in vitro and in vivo","volume":"7","author":"Kunisawa","year":"2012","journal-title":"PLoS One"},{"key":"R104-20250623","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrmicro.2017.50","article-title":"Transmission of the gut microbiota: spreading of health","volume":"15","author":"Browne","year":"2017","journal-title":"Nat Rev Microbiol"},{"key":"R105-20250623","first-page":"147","article-title":"Anti-virulence strategies to target bacterial infections.","volume":"398","author":"M\u00fchlen","year":"2016","journal-title":"Curr Top Microbiol Immunol"},{"key":"R106-20250623","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mib.2016.10.003","article-title":"Microbiome, metabolites and host immunity","volume":"35","author":"Levy","year":"2017","journal-title":"Curr Opin Microbiol"},{"key":"R107-20250623","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.3748\/wjg.v26.i20.2514","article-title":"Metabolomics profile in gastrointestinal cancers: update and future perspectives","volume":"26","author":"Nannini","year":"2020","journal-title":"World J Gastroenterol"},{"key":"R108-20250623","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab"},{"key":"R109-20250623","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/bmc.1671","article-title":"Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer","volume":"26","author":"Ikeda","year":"2012","journal-title":"Biomed Chromatogr"},{"key":"R110-20250623","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"R111-20250623","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.3748\/wjg.v24.i26.2818","article-title":"Biomarkers of gastric cancer: current topics and future perspective","volume":"24","author":"Matsuoka","year":"2018","journal-title":"World J Gastroenterol"},{"key":"R112-20250623","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11306-016-1094-6","article-title":"Metabolomics enables precision medicine: \u201cA White Paper, Community Perspective","volume":"12","author":"Beger","year":"2016","journal-title":"Metabolomics"},{"key":"R113-20250623","first-page":"294","article-title":"Metabolomics for the masses: the future of metabolomics in a personalized world","volume":"3","author":"Trivedi","year":"2017","journal-title":"New Horiz Transl Med"},{"key":"R114-20250623","doi-asserted-by":"crossref","first-page":"a000588","DOI":"10.1101\/mcs.a000588","article-title":"Metabolomics: an emerging but powerful tool for precision medicine","volume":"1","author":"Clish","year":"2015","journal-title":"Mol Case Stud"},{"key":"R115-20250623","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3390\/metabo9060108","article-title":"Translational metabolomics: current challenges and future opportunities","volume":"9","author":"Pinu","year":"2019","journal-title":"Metabolites"},{"key":"R116-20250623","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11306-018-1468-z","article-title":"Metabolomics in epidemiologic research: challenges and opportunities for early-career epidemiologists","volume":"15","author":"van Roekel","year":"2019","journal-title":"Metabolomics"},{"key":"R117-20250623","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.bbapap.2013.12.007","article-title":"Biomarker research with prospective study designs for the early detection of cancer","volume":"1844","author":"Pesch","year":"2014","journal-title":"Biochimica Et Biophysica Acta (BBA) - Proteins and Proteomics"},{"key":"R118-20250623","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/ng.2982","article-title":"An atlas of genetic influences on human blood metabolites","volume":"46","author":"Shin","year":"2014","journal-title":"Nat Genet"},{"key":"R119-20250623","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nature06244","article-title":"The human microbiome project","volume":"449","author":"Turnbaugh","year":"2007","journal-title":"Nature"},{"key":"R120-20250623","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1001\/jama.2014.4129","article-title":"Studying the elusive environment in large scale","volume":"311","author":"Patel","year":"2014","journal-title":"Jama"},{"key":"R121-20250623","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11306-021-01828-w","article-title":"Challenges in LC\u2013MS-based metabolomics for Alzheimer\u2019s disease early detection: targeted approaches versus untargeted approaches","volume":"17","author":"Reveglia","year":"2021","journal-title":"Metabolomics"},{"key":"R122-20250623","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature12820","article-title":"Diet rapidly and reproducibly alters the human gut microbiome","volume":"505","author":"David","year":"2014","journal-title":"Nature"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000002977","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T08:00:54Z","timestamp":1750665654000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000002977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":118,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000002977","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,19]]},"assertion":[{"value":"2024-08-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}